CFTR and cystic fibrosis: In these screening assays researchers use rectal biopsy samples obtained from CF patients to generate organoid cultures to study the effect of CFTR correctors and predict the drug response of the patients [64], whereas it may not be suitable in patients with remaining CFTR function [65].